Preferred Label : tagraxofusp;

CISMeF synonym : SL-401 fusion protein;

UNII : 8ZHS5657EH;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


https://www.has-sante.fr/jcms/p_3281016/fr/elzonris-tagraxofusp
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
tagraxofusp
Elzonris
Product containing only tagraxofusp in parenteral dose form (medicinal product form)
infusions, intravenous
tagraxofusp
adult
Blastic Plasmacytoid Dendritic Cell Neoplasm
histiocytic disorders, malignant
antineoplastic agents
evaluation of the transparency committee

---
https://www.ema.europa.eu/en/medicines/human/EPAR/elzonris
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
tagraxofusp
tagraxofusp
tagraxofusp
antineoplastic agents
antineoplastic agents
orphan drug production
adult
Blastic Plasmacytoid Dendritic Cell Neoplasm
infusions, intravenous
product surveillance, postmarketing
pregnancy
breast feeding
interleukin-3 receptor alpha subunit
drug evaluation, preclinical
recombinant fusion proteins
recombinant fusion proteins

---
Nous contacter.
27/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.